McGill University Health Centre/Research Institute of the McGill University Health Centre
529
100
121
210
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
7.8%
41 terminated/withdrawn out of 529 trials
83.7%
-2.9% vs industry average
16%
86 trials in Phase 3/4
10%
20 of 210 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (532)
Validation of a Wireless Wearable Vital Signs Monitor in Pediatric Patient
Role: lead
This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.
Role: lead
Miniaturized Vital Sign Monitoring for Newborns in the Delivery Room
Role: lead
Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition
Role: lead
Wireless MicroPremVitals Button Sensor in the NICU
Role: lead
Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit
Role: lead
The Effects of Oscillatory Positive Expiratory Pressure (OPEP) Therapy in Patients With COPD
Role: lead
BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort
Role: collaborator
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Role: collaborator
Safety and Efficacy of Canagliflozin in Advanced CKD
Role: lead
RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial
Role: lead
A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block
Role: lead
Minimal Effective Volume 90% for Double-injection Costoclavicular Block
Role: lead
Screening for Heart Failure Using a Multimodal Wearable Device
Role: lead
Secondary Prevention of Clostridioides Difficile Using Vancomycin
Role: lead
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Role: lead
Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism
Role: lead
Simultaneous Measurement and Responsive Treatment - Part 2
Role: collaborator
MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.
Role: collaborator
Radio-frequency (RF) Bladder Monitor
Role: lead